The Merck Childhood Asthma Network, Inc., (MCAN), is a non-profit, 501(c)(3) organization established to address the complex and growing problem of pediatric asthma in the United States. Funded by The Merck Company Foundation, the mission of MCAN is to support and advance evidence-based programs that improve the quality of life for children with asthma and their families and to reduce, through dissemination of effective interventions, the burden of the disease on them and society. The creation of MCAN is consistent with Merck's commitment to improving access to medicines, vaccines, and quality health care, and to building the capacity of health systems.

The content on this page was last modified on September 15, 2009.

Merck & Co., Inc., Whitehouse Station, NJ, USA, and Schering-Plough Corporation, Kenilworth, NJ, USA, are now one company. We have combined our global operations under the name Merck & Co., Inc. We are working to update our corporate responsibility Web site to reflect our new, combined, global organization.